ArticleNature communications2018

HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.

Liang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.